What are the primary, secondary, and relative causes of polycythemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Polycythemia

Classification Framework

Polycythemia is categorized into three distinct types: apparent (relative) polycythemia from plasma volume depletion, primary polycythemia from clonal hematopoietic disorders, and secondary polycythemia driven by either hypoxia-dependent or hypoxia-independent mechanisms. 1, 2


Apparent (Relative) Polycythemia

This represents false elevation without true increase in red cell mass:

  • Plasma volume depletion from severe dehydration, diarrhea, vomiting, diuretic use, capillary leak syndrome, or severe burns causes hemoconcentration that is clinically obvious 1, 2

  • Smoker's polycythemia is a real condition caused by chronic carbon monoxide exposure, which binds hemoglobin with 200-250 times greater affinity than oxygen, creating functional hypoxia; this resolves with smoking cessation 1, 2, 3


Primary Polycythemia

These are clonal disorders with autonomous red cell production:

  • Polycythemia vera (PV) is a JAK2-mutated myeloproliferative neoplasm characterized by low or inappropriately normal serum EPO levels, with JAK2 V617F mutation present in up to 97% of cases 1, 2

  • Familial polycythemia is an autosomal-dominant condition with activating mutations of the EPO receptor (EPOR), causing truncated receptors lacking negative regulatory domains 2, 4

  • Primary familial and congenital polycythemias result from inborn mutations affecting hematopoietic and erythroid cells, with molecular mechanisms varying between families 5, 6


Secondary Polycythemia: Hypoxia-Driven Causes

These represent physiologic compensation for tissue hypoxia:

  • Chronic lung disease (COPD, pulmonary fibrosis) triggers compensatory erythropoiesis through tissue hypoxia 1, 2, 3

  • Right-to-left cardiopulmonary vascular shunts and cyanotic congenital heart disease cause hypoxemia with compensatory erythrocytosis 1, 2, 3

  • High-altitude habitation leads to physiologic polycythemia as an adaptive response to reduced atmospheric oxygen 1, 2, 3

  • Hypoventilation syndromes including obstructive sleep apnea cause chronic intermittent hypoxia leading to compensatory erythrocytosis 1, 2, 3

  • High oxygen-affinity hemoglobinopathy (congenital, autosomal-dominant) causes functional tissue hypoxia despite normal oxygen saturation 3, 4

  • 2,3-bisphosphoglycerate (BPG) mutase deficiency results in impaired oxygen release to tissues 1, 4, 7

  • Methemoglobinemia causes functional hypoxia 4


Secondary Polycythemia: Hypoxia-Independent Causes

These produce EPO autonomously without hypoxic stimulus:

Malignant Tumors

  • Renal cell carcinoma produces EPO independently of hypoxia 1, 2, 3
  • Hepatocellular carcinoma produces EPO independently of hypoxia 1, 2, 3
  • Parathyroid carcinoma produces EPO autonomously 3

Benign Tumors

  • Cerebellar hemangioblastoma produces EPO independently of hypoxia 1, 2, 3
  • Uterine leiomyomas can produce EPO 1, 3
  • Pheochromocytoma can produce EPO 1, 3
  • Meningioma can produce EPO 1, 3

Congenital Disorders of Oxygen Sensing

  • Chuvash polycythemia results from homozygous germline mutations in the von Hippel-Lindau (VHL) gene, causing increased hypoxia-inducible factor-1 (HIF-1) expression in normoxic conditions with inappropriately elevated EPO levels 3, 6, 4

Other Causes

  • Post-renal transplant erythrocytosis (PRTE) 3, 6
  • Exogenous administration of erythropoietic drugs (EPO, androgen preparations, testosterone) 3

Key Diagnostic Discriminators

Serum EPO level is the critical discriminator between primary and secondary polycythemia:

  • Low or inappropriately normal EPO (present in 64-94% of PV cases) strongly suggests polycythemia vera with >90% specificity 1, 2, 3

  • Elevated EPO suggests secondary polycythemia, though EPO may normalize after hemoglobin stabilizes at a compensatory higher level in chronic hypoxic states 1, 3


Critical Pitfalls to Avoid

  • Do not assume normal EPO excludes PV - EPO sensitivity for PV is only 64-70%; normal EPO with elevated hemoglobin still requires JAK2 testing 3

  • Do not overlook smoking as a cause - smoker's polycythemia is real and resolves with cessation, with risk reduction beginning within 1 year 1, 2, 3

  • Do not misinterpret normal EPO in chronic hypoxic states - levels may normalize after hemoglobin stabilizes at a higher compensatory level, potentially mimicking polycythemia vera 1, 3

  • Do not perform aggressive routine phlebotomies in secondary polycythemia - this risks iron depletion, decreased oxygen-carrying capacity, and paradoxically increased stroke risk 3

References

Guideline

Polycythemia Causes and Diagnostic Approach

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Polycythemia Classification and Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Secondary Polycythemia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Primary polycythemias.

Current opinion in hematology, 1995

Research

Polycythemia and oxygen sensing.

Pathologie-biologie, 2004

Research

Congenital and acquired polycythemias.

Deutsches Arzteblatt international, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.